Targeting HuR to improve a synthetic lethal therapy for pancreatic cancer
$27,929R01FY2019CANIH
Thomas Jefferson University, Philadelphia PA
Investigators
Linked publications, trials & patents
Paper 39763867Paper 38843355Paper 37683260Paper 37380658Paper 37089813Paper 37004490Paper 35740940Paper 35703534Paper 35681100Paper 35406624Paper 35132620Paper 34082100Paper 34021072Paper 33593942Paper 33361273Paper 33257507Paper 32561076Paper 32135080Paper 32058016Paper 31970930Paper 31870164Paper 31676541Paper 31383722Paper 31273064Paper 30631752Paper 30378060Paper 30266763Paper 30266754Paper 30234181Paper 30092282Paper 29853643Paper 29579325Paper 29483142Paper 29452455Paper 29133460Paper 28687616Paper 28652247Paper 28242812Paper 27893535Patent 12447147
Abstract
Abstract No changes from the parent R01.
View original record on NIH RePORTER →